ライフサイエンスコーパス: give informed consent

1 tutional review board approval, and patients gave informed consent.

2 onal review board approval, and all patients gave informed consent.

3 institutional review board, and all patients gave informed consent.

4 All subjects gave informed consent.

5 All patients gave informed consent.

6 Participants gave informed consent.

7 itutional ethics committee, and all patients gave informed consent.

8 Readers gave informed consent.

9 ter number, PR(HG)36/2000), and all patients gave informed consent.

10 Institutional Review Board, and all subjects gave informed consent.

11 All participating women gave informed consent.

12 tutional review boards, and all participants gave informed consent.

13 All patients gave informed consent.

14 oard approval was obtained, and participants gave informed consent.

15 The participating radiologists gave informed consent.

16 itutional review board, and all participants gave informed consent.

17 d and was compliant with HIPAA; each patient gave informed consent.

18 oved by a human research committee; patients gave informed consent.

19 Patients gave informed consent.

20 in two groups, recent MI and chronic MI, and gave informed consent.

21 sented for primary care on selected days and gave informed consent.

22 Each subject gave informed consent.

23 William Beaumont Hospital, and all patients gave informed consent.

24 nteer and in a patient with MS, both of whom gave informed consent.

25 patient, or members of the patient's family, gave informed consent.

26 All subjects gave informed consent.

27 for scanning the 10 volunteers, all of whom gave informed consent.

28 and the subjects and/or a parent or guardian gave informed consent.

29 regional ethics committee, and all patients gave informed consent.

30 ds approved this study, and all participants gave informed consent.

31 nstitutional review board-approved study and gave informed consent.

32 titutional review board and all participants gave informed consent.

33 itutional review board, and all participants gave informed consent.

34 ard approved the study, and all participants gave informed consent.

35 isease, before subjects lose the capacity to give informed consent.

36 utional review board-approved study, and all gave informed consent; 20 volunteers were healthy subjec

37 All patients gave informed consent according to an institutionally ap

38 Participating patients and families gave informed consent and chose between nonoperative man

39 Of 986 eligible patients, 674 gave informed consent and returned a complete questionna

40 All subjects participating in DMIST gave informed consent and the study was HIPAA-compliant.

41 5.6 [standard deviation]; range, 8-66 years) gave informed consent and underwent MR spectroscopy and

42 Participants gave informed consent and were instructed on use of oral

43 an age, 57.1 years; range, 50-69 years), who gave informed consent and who had suspicious screening m

44 women of reproductive age (15-45 years) who gave informed consent and who planned to remain in the a

45 Parent(s) of all subjects gave informed consent (and children gave assent) for par

46 le if they were older than 18 years, able to give informed consent, and had circular or oval postoper

47 Patients gave informed consent for all procedures.

48 5125 patients gave informed consent for genotyping.

49 controls from three beryllium industries who gave informed consent for participation.

50 All subjects or their legal representatives gave informed consent for participation.

51 All parents gave informed consent for patient sedation.

52 All patients gave informed consent for this institutional review boar

53 weight, 78.9 kg +/- 18.3; 12 men, 10 women) gave informed consent for this prospective institutional

54 Patients gave informed consent for use of medical records.

55 tive review from patients who had previously given informed consent for prospective studies.

56 nt whole-brain (18)F-fluorocholine PET after giving informed consent in this institutional review boa

57 at all donors of biological materials should give informed consent, including oocyte and sperm donors

58 After giving informed consent, patients with symptomatic leiom

59 All subjects gave informed consent to participate and were examined u

60 ho were part of the follow-on clinical trial gave informed consent to participate in a longitudinal n

61 Parents and children gave informed consent to participate in the research.

62 Institutional review board approval was given; informed consent was waived.

63 re defined and eligible individuals, who had given informed consent, were vaccinated and followed up